title: When azanucleoside treatment can be curative: nonintensive bridging strategy before allografting in older patients with myelodysplastic syndrome/acute myeloid leukemia.
authors.forename: Michael
authors.initials: M
authors.lastname: Lübbert
authors.forename: Hartmut
authors.initials: H
authors.lastname: Bertz
authors.forename: Michael Josef
authors.initials: MJ
authors.lastname: Müller
authors.forename: Jürgen
authors.initials: J
authors.lastname: Finke
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000031:analogs & derivatives*; D002755:Choice Behavior; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D010166:Palliative Care; D010358:Patient Participation
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D001374:Azacitidine